Aspen Pharmacare is continuing to deliver on its promise to streamline its portfolio while paying off debt, with the agreed sale of six products it currently offers in its native South Africa to Switzerland’s Acino for approximately ZAR1.8bn ($122m), plus inventory costs.
Products included in the transaction are Altosec (omeprazole) and Trustan (esomeprazole), the granisetron-containing Grantryl and Aspen